Patent · US Active

Antibodies against human CSF-1R and uses thereof

US10023643B2 · kind B2 · utility

5Cited by
29References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 12, 2012
Grant dateJul 17, 2018
Priority date
Expiry dateNov 9, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to antibodies against human CSF-1R (CSF-1R antibody), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.